載入...
Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines
BACKGROUND & AIMS: It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describ...
Na minha lista:
| 發表在: | JHEP Rep |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898178/ https://ncbi.nlm.nih.gov/pubmed/33665586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100227 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|